Drug Trial Radar · NCT07011706
ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
110
Actual
Start
May 30, 2025
Primary completion
Sep 21, 2026
Study completion Nov 24, 2026
Sponsor
- Lead sponsor
- Aclaris Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.
Conditions
- Atopic Dermatitis
- Atopic
- Dermatitis
- AD
- Eczema
Interventions
ATI-045Drug
ATI-045 group
PlaceboDrug
Placebo group
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change in Eczema Area and Severity Index (EASI)Time frame: Baseline to Week 24
Locations
60 sites in 2 countries. Site status is shown where the registry gives one.
Aclaris Clinical Site
Phoenix, Arizona
Aclaris Clinical Site
Tucson, Arizona
Aclaris Study Site
Bryant, Arkansas
Aclaris Clinical Site
Beverly Hills, California
Aclaris Study Site
Encinitas, California
Aclaris Clinical Site
Encino, California
Aclaris Clinical Site
Huntington Beach, California
Aclaris Study Site
Los Angeles, California
Aclaris Study Site
Oceanside, California
Aclaris Study Site
Santa Monica, California
Aclaris Clinical Site
Sherman Oaks, California
Aclaris Clinical Site
Thousand Oaks, California
Aclaris Study Site
Coral Gables, Florida
Aclaris Clinical Site
Hollywood, Florida
Aclaris Clinical Site
Jacksonville, Florida
Aclaris Clinical Site
Margate, Florida
Aclaris Study Site
North Miami Beach, Florida
Aclaris Study Site
Sweetwater, Florida
Aclaris Study Site
Tampa, Florida
Aclaris Clinical Site
Wellington, Florida
Aclaris Clinical Site
Atlanta, Georgia
Aclaris Clinical Site
Savannah, Georgia
Aclaris Study Site
Boise, Idaho
Aclaris Study Site
Clarksville, Indiana
Aclaris Study Site
Indianapolis, Indiana
Aclaris Clinical Site
Lafayette, Indiana
Aclaris Study Site
West Lafayette, Indiana
Aclaris Study Site
Bowling Green, Kentucky
Aclaris Clinical Site
Ann Arbor, Michigan
Aclaris Study Site
Auburn Hills, Michigan
Aclaris Clinical Site
Troy, Michigan
Aclaris Clinical Site
Ridgeland, Mississippi
Aclaris Study Site
Saint Joseph, Missouri
Aclaris Clinical Site
Missoula, Montana
Aclaris Study Site
New York, New York
Aclaris Study Site
New York, New York
Aclaris Clinical Site
New York, New York
Aclaris Clinical Site
The Bronx, New York
Aclaris Clinical Site
Cary, North Carolina
Aclaris Clinical Site
Wilmington, North Carolina
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.